ET Pharma

AbbVie expands Oxford R&D facility as part of £120 million-plus investment

Nov 4, 2026, 6:44 AM

Translate article text

Choose a language and wait for the translated text.

The investment comes a few months after the US and Britain finalised an agreement aimed at increasing UK medicine prices in line with President Donald Trump's new US pricing policies.

AbbVie expands Oxford R&amp;D facility as part of £120 million-plus investment

AbbVie expands Oxford R&D facility as part of £120 million-plus investment